CY1116106T1 - METHOD OF PREVENTION OR INFECTION TREATMENT M. TUBERCULOSIS - Google Patents

METHOD OF PREVENTION OR INFECTION TREATMENT M. TUBERCULOSIS

Info

Publication number
CY1116106T1
CY1116106T1 CY20141101023T CY141101023T CY1116106T1 CY 1116106 T1 CY1116106 T1 CY 1116106T1 CY 20141101023 T CY20141101023 T CY 20141101023T CY 141101023 T CY141101023 T CY 141101023T CY 1116106 T1 CY1116106 T1 CY 1116106T1
Authority
CY
Cyprus
Prior art keywords
tuberculosis
prevention
infection treatment
polypeptides
infection
Prior art date
Application number
CY20141101023T
Other languages
Greek (el)
Inventor
Martine Marchand
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11190079.1A external-priority patent/EP2426141B1/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of CY1116106T1 publication Critical patent/CY1116106T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει πολυπεπτίδια, πολυνουκλεοτίδια που περιλαμβάνουν αλληλουχία νουκλεϊνικού οξέος που κωδικοποιεί τα εν λόγω πολυπεπτίδια και σχετικές φαρμακευτικές συνθέσεις.The present invention provides polypeptides, polynucleotides comprising a nucleic acid sequence encoding said polypeptides and related pharmaceutical compositions.

CY20141101023T 2005-04-29 2014-12-09 METHOD OF PREVENTION OR INFECTION TREATMENT M. TUBERCULOSIS CY1116106T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67654905A 2005-04-29 2005-04-29
US77701706A 2006-02-27 2006-02-27
EP11190079.1A EP2426141B1 (en) 2005-04-29 2006-04-27 Method for preventing or treating M tuberculosis infection

Publications (1)

Publication Number Publication Date
CY1116106T1 true CY1116106T1 (en) 2017-02-08

Family

ID=58457259

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141101023T CY1116106T1 (en) 2005-04-29 2014-12-09 METHOD OF PREVENTION OR INFECTION TREATMENT M. TUBERCULOSIS
CY20141101024T CY1115823T1 (en) 2005-04-29 2014-12-09 NEW METHOD FOR PREVENTION OR TREATMENT OF INFECTION M. TUBERCULOSIS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20141101024T CY1115823T1 (en) 2005-04-29 2014-12-09 NEW METHOD FOR PREVENTION OR TREATMENT OF INFECTION M. TUBERCULOSIS

Country Status (1)

Country Link
CY (2) CY1116106T1 (en)

Also Published As

Publication number Publication date
CY1115823T1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
CY1119106T1 (en) ANTIBODIES AGAINST MASP-2
BRPI0508064A (en) flavivirus, vaccine composition and nucleic acid molecule
EP2426141A3 (en) Method for preventing or treating M tuberculosis infection
CY1118038T1 (en) FOLLOWED PHARMACEUTICAL FORMS OF THERAPEUTIC DISPOSAL
CY1118090T1 (en) Recombinant RSV antigens
CY1115745T1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF OXALIC DISEASES
DK1731605T3 (en) Cancer antigen peptides derived from WT1
NO20092611L (en) Crystalline solid Rasagilin base
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
SE0302811D0 (en) Novel compounds
NO20005224D0 (en) BTK inhibitors and methods for their identification and use
BRPI0519047A2 (en) Method for the production of a marker contrast agent or marker therapeutic agent, marker contrast agents and use of marker contrast agents or marker therapeutic agents
CY1110221T1 (en) STANDARD Sodium Pharmaceutical Formulations MODELUKASTIS
EA201001322A1 (en) VACCINES AGAINST CHLAMIDIOSIS
NO20054329D0 (en) Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
CY1108843T1 (en) 3,11B CIS DIMRODETRETRAVENASINE FOR THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOLOGIES
CY1109465T1 (en) NEW PHARMACEUTICAL MEDICINES FORMONTAFINILIS
ATE415166T1 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS
CY1107146T1 (en) METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE (AD)
CY1107841T1 (en) PHARMACEUTICAL PARTICULARS CONTAINING MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT
CY1107419T1 (en) ANTI-VIRUSAL PRODUCTS FROM Piperazine and Substituted Piperidine
BRPI0606687A2 (en) nutraceutical compositions
CY1112591T1 (en) FROM THE ORAL PHARMACEUTICAL FORMS OF CLANDRIVIN
NO20091955L (en) Antiviral compositions and methods of use
CY1114614T1 (en) BLOOD FLU ANTIGENS ANTIGONS AND DISTRIBUTED DNA FRAGMENTS